Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H17ClN3O3P |
| Molecular Weight | 413.794 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[P@](=O)(C1=C(NC2=C1C=C(Cl)C=C2)C(N)=O)C3=CC(C)=CC(\C=C\C#N)=C3
InChI
InChIKey=CGBYTKOSZYQOPV-CCEZBSFNSA-N
InChI=1S/C20H17ClN3O3P/c1-12-8-13(4-3-7-22)10-15(9-12)28(26,27-2)19-16-11-14(21)5-6-17(16)24-18(19)20(23)25/h3-6,8-11,24H,1-2H3,(H2,23,25)/b4-3+/t28-/m0/s1
| Molecular Formula | C20H17ClN3O3P |
| Molecular Weight | 413.794 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the Phase IIb evaluation of fosdevirine (GSK2248761). | 2014 |
|
| Central nervous system disposition and metabolism of Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: an LC-MS and Matrix-assisted laser desorption/ionization imaging MS investigation into central nervous system toxicity. | 2013-02-18 |
|
| Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease. | 2010-10-15 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:12:46 GMT 2025
by
admin
on
Mon Mar 31 19:12:46 GMT 2025
|
| Record UNII |
Z4I0C281BJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
WW-17
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
Z4I0C281BJ
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
C170008
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104968
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
100000174902
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
DTXSID501031227
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
9289
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
1018450-26-4
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
44224276
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
DB06166
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY | |||
|
Fosdevirine
Created by
admin on Mon Mar 31 19:12:46 GMT 2025 , Edited by admin on Mon Mar 31 19:12:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR | |||
|
|
TARGET ORGANISM->INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |